(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -9.76%2.33B | -20.80%2.81B | -6.99%2.83B | -21.95%3.03B | -16.36%2.59B | 33.73%3.54B | 24.69%3.04B | 24.63%3.88B | 98.02%3.09B | 40.91%2.65B |
Transactional financial assets | 29.29%1.28B | 46.15%1.33B | 1.48%1.37B | 51.16%1.3B | 32.66%990M | 40.81%910M | 93.89%1.35B | 249.21%860M | 49.25%746.27M | 546.27%646.27M |
Notes receivable and accounts receivable | -23.57%67.4M | -20.83%80.32M | -26.05%92.33M | 11.06%79.2M | -55.81%88.19M | -43.51%101.45M | 21.10%124.86M | -50.80%71.32M | 296.27%199.56M | 310.56%179.6M |
-Notes receivable | ---- | ---- | --31.75M | --31.75M | 6.37%31.75M | 6.37%31.75M | ---- | ---- | --29.85M | --29.85M |
-Accounts receivable | 19.43%67.4M | 15.24%80.32M | -51.48%60.58M | -33.47%47.45M | -66.74%56.44M | -53.45%69.7M | 21.10%124.86M | -50.80%71.32M | 236.99%169.71M | 242.32%149.75M |
Other receivables (including interest and dividends) | 75.69%36.8M | -24.78%12.71M | -1.10%12.5M | 8.80%14.53M | 53.86%20.95M | 14.20%16.9M | -26.43%12.64M | -19.82%13.36M | -17.35%13.61M | -3.85%14.8M |
-Other receivable | ---- | ---- | ---- | 8.80%14.53M | ---- | 14.20%16.9M | ---- | -19.82%13.36M | ---- | -3.85%14.8M |
Advance payment | 19.85%819.65M | 80.61%591.23M | 1.26%737.06M | 40.67%519.94M | 30.68%683.87M | 40.48%327.35M | -0.11%727.88M | 19.66%369.62M | 2.31%523.32M | 16.02%233.02M |
Inventories | 3.48%642.57M | -4.50%644.91M | 0.95%508.99M | 7.51%493.15M | 21.11%620.94M | 12.21%675.3M | 14.64%504.2M | 14.25%458.71M | 29.86%512.71M | 32.28%601.85M |
Receivable financing | -26.42%34.42M | 80.69%16.26M | -31.15%22.28M | -34.98%27.66M | -32.44%46.78M | -93.32%9M | -79.85%32.36M | -69.38%42.54M | 78.21%69.25M | 309.24%134.82M |
Other current assets | 50.47%41.32M | 21.69%38.69M | 51.18%32.96M | 861.98%20.22M | -76.29%27.46M | -77.64%31.79M | -81.97%21.8M | -98.16%2.1M | -13.54%115.83M | -10.43%142.19M |
Total current assets | 3.78%5.25B | -1.69%5.52B | -3.62%5.6B | -3.76%5.48B | -3.95%5.06B | 22.01%5.62B | 23.58%5.81B | 27.04%5.7B | 64.38%5.27B | 59.40%4.6B |
Non Current assets | ||||||||||
Other equity investment | -12.00%25.37M | -18.19%29.49M | 43.48%33.45M | 0.62%33.61M | 24.70%28.83M | 17.60%36.05M | -13.73%23.31M | 20.91%33.4M | -20.95%23.12M | 6.92%30.65M |
Long-term equity investment | -44.84%20.07M | -43.80%20.61M | -69.72%20.88M | -69.33%21.65M | -65.28%36.38M | -69.41%36.67M | -59.76%68.94M | -61.35%70.59M | -46.54%104.79M | -37.50%119.88M |
Fixed assets | ---- | ---- | ---- | -4.11%3.78B | ---- | -4.58%3.88B | ---- | 0.71%3.94B | ---- | -1.21%4.07B |
Fixed assets liquidation | ---- | ---- | ---- | 171.26%16.53M | ---- | 320.69%17.18M | ---- | 85.18%6.09M | ---- | -1.05%4.08M |
Constru in process | ---- | ---- | ---- | 23.84%387.76M | ---- | 15.88%327.71M | ---- | -35.56%313.12M | ---- | -18.42%282.81M |
Productive biological assets | --790.01K | --636.94K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Intangible assets | 2.31%113.79M | -14.48%112.07M | -16.75%109.96M | -16.83%110.76M | -17.15%111.22M | -3.16%131.06M | -3.66%132.09M | -2.94%133.17M | -2.91%134.25M | -5.47%135.33M |
Long deferred expense | -10.20%53.21M | -10.20%54.71M | -2.17%56.2M | -2.37%57.69M | -2.78%59.26M | -3.10%60.92M | -11.16%57.44M | -11.24%59.09M | -11.05%60.95M | -10.72%62.87M |
Deferred tax assets | -6.59%69.5M | -6.82%70.62M | 87.73%72M | 85.04%66.09M | 115.99%74.4M | 7.87%75.79M | -40.48%38.35M | -39.14%35.72M | -38.99%34.45M | 25.60%70.26M |
Usufruct assets | -12.96%232.94M | -10.65%241.61M | -10.13%250.28M | -9.87%258.95M | -10.55%267.62M | -12.13%270.41M | --278.48M | --287.31M | --299.19M | -10.00%307.74M |
Other non current assets | 126.65%12.6M | 217.85%24.78M | 878.09%29.67M | 431.57%19.22M | 83.17%5.56M | 126.05%7.8M | -29.31%3.03M | -11.75%3.62M | -35.67%3.03M | -39.76%3.45M |
Total non current assets | 1.84%4.87B | 0.50%4.87B | 0.53%4.82B | -2.70%4.75B | -3.97%4.79B | -4.72%4.84B | -0.62%4.79B | 0.08%4.89B | 1.28%4.98B | -4.17%5.08B |
Total assets | 2.84%10.13B | -0.68%10.39B | -1.74%10.42B | -3.27%10.24B | -3.96%9.85B | 7.98%10.46B | 11.33%10.61B | 12.99%10.58B | 26.18%10.25B | 18.24%9.69B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | ---- | ---- | ---- | --150.14M | --150.14M | --150.14M | --150M | ---- | ---- | ---- |
Notes payable and accounts payable | 27.10%2.14B | 2.16%2.41B | -3.85%2.33B | -17.91%2.14B | -34.23%1.69B | 10.53%2.36B | 13.73%2.42B | 21.88%2.61B | 103.48%2.56B | 99.50%2.13B |
-Notes payable | 29.89%1.91B | 0.72%2.12B | -5.12%2.09B | -19.71%1.86B | -37.98%1.47B | 11.63%2.1B | 18.47%2.2B | 26.28%2.32B | 142.18%2.37B | 141.20%1.88B |
-Accounts payable | 8.05%233.44M | 14.07%288.82M | 9.03%236.12M | -3.73%283.4M | 11.73%216.05M | 2.12%253.2M | -19.17%216.57M | -4.34%294.38M | -31.26%193.37M | -13.76%247.94M |
Contract liabilities | 7.96%321.04M | -30.03%184.36M | -14.89%358.04M | -17.15%237.89M | -21.12%297.37M | 61.11%263.47M | 10.59%420.67M | -24.58%287.12M | 29.41%376.99M | -2.31%163.53M |
Salaries payable | 7.47%72.92M | -0.87%160.09M | 3.66%119.81M | -1.29%109.51M | 145.79%67.85M | 39.44%161.49M | 70.02%115.58M | 1,374.62%110.94M | 306.22%27.6M | 85.25%115.82M |
Taxs payable | -55.05%29.57M | 0.01%49.25M | -17.28%55.21M | -31.82%46.2M | 95.37%65.78M | 3.55%49.25M | 181.42%66.75M | 137.38%67.76M | 65.17%33.67M | 337.03%47.56M |
Other payable (including interest and dividends) | 176.37%287.32M | 170.38%275.86M | 4.97%112.51M | -4.15%95.72M | 8.51%103.96M | 13.84%102.02M | 27.94%107.18M | 23.20%99.86M | 25.98%95.81M | -5.89%89.62M |
-Other payable | ---- | ---- | ---- | -4.15%95.72M | ---- | 13.84%102.02M | ---- | 23.20%99.86M | ---- | -5.89%89.62M |
Non current liabilities due within one year | 4.19%202.05M | 5.43%203.53M | 4.15%200.57M | 5.12%198.09M | 4.99%193.92M | 4.35%193.04M | 123.29%192.58M | 55.25%188.44M | 113.94%184.7M | 63.02%184.99M |
Other current liabilities | -8.84%29.95M | -31.47%17.51M | -17.26%38.41M | -19.12%23.28M | -11.39%32.86M | 54.74%25.56M | 21.51%46.42M | 14.15%28.79M | 15.78%37.08M | 4.20%16.52M |
Total current liabilities | 18.78%3.09B | -0.11%3.3B | -8.75%3.21B | -11.48%3B | -21.74%2.6B | 20.05%3.3B | 25.33%3.52B | 21.79%3.39B | 87.25%3.32B | 79.27%2.75B |
Current liabilities | ||||||||||
Long term loan | -38.48%279.99M | -31.90%365.62M | -31.90%365.62M | -27.06%451.25M | -18.56%455.1M | -23.35%536.87M | -30.33%536.87M | -20.52%618.65M | -31.30%558.81M | -18.20%700.42M |
Long term salaries pay | ---- | ---- | 63.21%4.57M | 63.21%4.57M | 63.21%4.57M | 63.21%4.57M | -35.85%2.8M | 56.10%2.8M | -35.85%2.8M | -35.85%2.8M |
Deferred tax liabilities | -12.51%40.68M | -11.88%42.63M | 845.65%44.54M | 637.43%45.89M | 893.25%46.5M | 732.36%48.37M | -10.56%4.71M | 16.18%6.22M | -16.41%4.68M | 5.40%5.81M |
Long term deferred income | 22.01%72.6M | -2.76%59.23M | -5.14%60.23M | -5.85%62.27M | -5.99%59.5M | -5.65%60.92M | -3.55%63.49M | -1.43%66.13M | 1.73%63.29M | 1.74%64.56M |
Lease liabilities | -12.34%212.86M | -11.34%219.84M | -10.48%230.13M | -9.20%238.52M | -16.20%242.83M | -13.38%247.97M | --257.07M | --262.68M | --289.77M | -9.06%286.28M |
Total non current liabilities | -25.03%606.13M | -23.52%687.32M | -18.48%705.09M | -16.10%802.49M | -12.06%808.49M | -15.21%898.7M | 2.23%864.94M | 12.19%956.48M | 3.81%919.36M | -14.83%1.06B |
Total liabilities | 8.38%3.69B | -5.12%3.98B | -10.67%3.92B | -12.49%3.81B | -19.64%3.41B | 10.24%4.2B | 19.98%4.38B | 19.54%4.35B | 59.46%4.24B | 37.12%3.81B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%1.57B | 0.00%1.57B | 0.00%1.57B | 0.00%1.57B | 0.00%1.57B | 0.00%1.57B | 0.00%1.57B | 0.00%1.57B | 0.00%1.57B | 0.00%1.57B |
Capital reserve funds | 0.01%5.78B | 0.14%5.78B | 0.14%5.78B | 0.14%5.78B | 0.14%5.78B | 0.01%5.78B | 0.00%5.77B | 0.03%5.77B | 0.03%5.77B | 0.03%5.77B |
Surplus reserve funds | 0.00%459.86M | 0.00%459.86M | 0.00%459.86M | 0.00%459.86M | 0.00%459.86M | 0.00%459.86M | 0.00%459.86M | 0.00%459.86M | 0.00%459.86M | 0.00%459.86M |
Retained profit | 0.70%-1.41B | 9.44%-1.44B | 16.28%-1.35B | 10.91%-1.43B | 22.10%-1.42B | 18.82%-1.59B | 17.12%-1.62B | 23.09%-1.61B | 22.77%-1.82B | 18.57%-1.96B |
Other composite income | -18.00%12.81M | -25.03%16.31M | 45.88%19.67M | -10.18%19.8M | 17.29%15.62M | 10.32%21.75M | -18.78%13.48M | 28.86%22.05M | -28.01%13.31M | 9.52%19.72M |
Specific reserves | -54.14%11.49M | -50.71%11.1M | 10.49%22.74M | 72.09%29.03M | 88.71%25.05M | 135.69%22.52M | 116.36%20.58M | 133.34%16.87M | 174.58%13.27M | 271.47%9.56M |
Shareholders equity without minority interests | -0.09%6.43B | 2.25%6.4B | 4.49%6.5B | 3.11%6.42B | 7.05%6.44B | 6.53%6.26B | 5.81%6.22B | 8.72%6.23B | 9.88%6.01B | 8.43%5.88B |
Minority interests | 4.31%5.7M | 112.73%5.69M | 175.26%5.43M | 173.80%5.43M | 138.09%5.46M | -21.37%2.67M | 134.69%1.97M | 156.44%1.98M | 163.58%2.29M | 213.97%3.4M |
Total shareholder equity | -0.09%6.44B | 2.30%6.41B | 4.54%6.51B | 3.16%6.43B | 7.10%6.44B | 6.52%6.26B | 5.95%6.22B | 8.83%6.23B | 9.99%6.01B | 8.55%5.88B |
Total liabilityies and equity | 2.84%10.13B | -0.68%10.39B | -1.74%10.42B | -3.27%10.24B | -3.96%9.85B | 7.98%10.46B | 11.33%10.61B | 12.99%10.58B | 26.18%10.25B | 18.24%9.69B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Sichuan Huaxin (Group) Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data